Stocktoria
Viking Therapeutics, Inc. VKTX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2015-04-29
Viking Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 6,026,131 | $319.4M |
| TWO SIGMA INVESTMENTS, LP | 4,432,142 | $144.2M |
| CITADEL ADVISORS LLC | 2,615,121 | $85.1M |
| D. E. Shaw & Co., Inc. | 1,676,713 | $54.6M |
| MILLENNIUM MANAGEMENT LLC | 376,225 | $12.2M |
| Bridgewater Associates, LP | 71,229 | $2.3M |
| Point72 Asset Management, L.P. | 19,000 | $618,260 |
| AQR CAPITAL MANAGEMENT LLC | 12,172 | $390,000 |
Source: SEC EDGAR filings · CIK 0001607678 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.